Importantly, we explored the mechanism of how DOR activation promotes breast cancer progression, finding strong induction of oncogenic JAK1/2-STAT3 signaling and epithelial-mesenchymal transition (EMT) markers. Here, OPRD1 is linked to breast cancer.